2026 China Inbound Medical Industry Whitepaper: Key Findings

The 2026 whitepaper estimates that foreign patient visits to Chinese hospitals continue to grow at double-digit rates, with revenue concentrated in oncology, cardiology and health screening. It documents wide variation in service maturity between coastal cities and inland centres, and highlights language capability as the most frequently cited operational bottleneck. The institutional edition includes benchmark data on pricing, length of stay and payer mix.